ProShare Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

ProShare Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,655	Closed	-$29K	–	1698
2015 Q4	$29K	Buy	+11,655	New	+$34.6K	﹤0.01%	1697
2015 Q3	–	Sell	-10,104	Closed	-$32K	–	1639
2015 Q2	$32K	Sell	10,104 -4,573	-31%	-$15.7K	﹤0.01%	1632
2015 Q1	$42K	Sell	14,677 -1,638	-10%	-$4.19K	﹤0.01%	1881
2014 Q4	$42K	Sell	16,315 -13,862	-46%	-$60.7K	﹤0.01%	1930
2014 Q3	$225K	Sell	30,177 -6,848	-18%	-$64K	﹤0.01%	1903
2014 Q2	$436K	Sell	37,025 -11,383	-24%	-$121K	0.01%	1673
2014 Q1	$562K	Buy	+48,408	New	+$570K	0.01%	1778
2013 Q4	–	Sell	-30,206	Closed	-$325K	–	2279
2013 Q3	$325K	Buy	30,206 +8,902	+42%	+$101K	0.01%	1842
2013 Q2	$250K	Buy	+21,304	New	+$213K	﹤0.01%	1864

Other funds holding SZYM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

ProShare Advisors's SZYM Position: Q1 2016 in Review

ProShare Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2016, closing a stake of 11,655 shares — an estimated $29K sold.

ProShare Advisors first reported a position in SZYM in Q2 2013 and held it in 9 quarters. The position peaked at $562K in Q1 2014. 99 funds tracked by Wall St. Rank hold SZYM as of Q1 2016.

ProShare Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
ProShare Advisors sold 11,655 SOLAZYME INC COM STK (DE) shares in Q1 2016, an estimated $29K.
ProShare Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 9 quarters.
ProShare Advisors's SOLAZYME INC COM STK (DE) position peaked at $562K in Q1 2014.
99 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2016.

Based on ProShare Advisors's 13F filing for Q1 2016, filed 6 May 2016.